Credit Suisse Reiterates Outperform on Quest Diagnostics (DGX) Following GAO Report

December 17, 2018 7:48 AM EST Send to a Friend
Credit Suisse analyst, A.J. Rice, reiterated an Outperform rating and $103.00 price target on Quest Diagnostics (NYSE: DGX) following a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login